Skip to main content
Premium Trial:

Request an Annual Quote

Quest to Use CollabRx's Genetic Variant Annotation Services in NGS Testing

NEW YORK (GenomeWeb) – Data analytics firm CollabRx has inked a non-exclusive deal with Quest Diagnostics to provide the company with its medical annotation services.

Under the agreement, Quest will have access to medical content services from CollabRx, such as scientific literature, medical guidelines, and published therapeutic protocols. The services, marketed as Genetic Variant Annotation, were developed by CollabRx but customized by Quest.

Doctors that use Quest's next-generation sequencing services to perform genetic analysis on cancer patients will have access to this medical content to help them guide treatment strategies. “The annotated content may help physicians better understand, through the database, the clinical significance of test results indicating the presence of one or more gene mutations,” CollabRx said in a statement, highlighting that Quest each year serves approximately half the physicians and hospitals in the US.

As part of the deal, Quest can also use CollabRx content to inform clinical trials that it is performing with drug developers and other partners.

The firms did not disclose additional details of their agreement.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.